Jeffrey Hammerbacher, BA | Authors

Articles

Mutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy

December 15, 2015

Because of the abundance of promising preclinical and early-phase clinical data, mutation-derived tumor antigens an exciting new class of targets in cancer immunotherapy.